Search clinical trials for: Pronator Teres Release

Total 5322 results

Javelin Pharmaceuticals

Completed

Efficacy and Safety of Intranasal Morphine for Pain After Third Molar Extraction

Post-Operative Pain | Third Molar Extraction
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Potential of DVS SR to Inhibit the CYP2D6 Pathway

Diabetic Neuropathies | Vasomotor Symptoms | Fibromyalgia | Depressive Disorder, Major
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Desvenlafaxine Sustained-Release (DVS-SR) in Adult Outpatients With Major Depressive Disorder

Major Depressive Disorder

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Safety, Tolerability, and PK of DVS SR in Healthy Japanese Women

Vasomotor Symptoms
Novartis

Completed

Efficacy, Tolerability and Safety of Dexmethylphenidate HCl Extended-Release Capsules in Children With Attention-Deficit/Hyperactivity Disorder

ADHD, ADD

United States
Novartis

Completed

Placebo-Controlled Comparison of Two Different Brands of Modified-Release Oral Dosage Forms Regarding Safety and Efficacy in Children With Attention Deficit Hyperactivity Disorder (ADHD) Aged 6 - 14

ADHD

Germany
Creighton University
Shire

Unknown

Open Label Study of Lithium Plus Extended-Release Carbamazepine (ERC-CBZ) for Rapid Cycling Bipolar Disorder

Bipolar Disorder

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating DVS SR in Patients With Fibromyalgia Syndrome

Fibromyalgia

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evalutating the Pharmacokinetics (PK) and Safety of a Single Dose of Desvenlafaxine Sustained Release (DVS SR)

Depressive Disorder, Major

United States
Handok Inc.

Completed

Phase III Study for Glimepiride + Metformin Hydrochloride (Amaryl M) Slow Release (SR)

Diabetes Mellitus, Type 2

Korea, Republic of
Walter Reed Army Medical Center

Unknown

Comparison of Biofeedback vs. Botox Injection to Treat Levator Ani Syndrome

Levator Ani Syndrome With Pain and/or Constipation Symptoms.

United States
AstraZeneca

Terminated

Rapid Versus Conventional Titration of Quetiapine in Schizophrenia/Schizoaffective Disorder (RAPID)

Psychotic Disorders | Schizophrenia | Schizoaffective Disorders

United Kingdom
University Hospital, Geneva
Ligue Pulmonaire Genevoise

Completed

Use of a Gamma-IFN Assay in Contact Tracing for Tuberculosis in a Low-Incidence, High Immigration Area

Tuberculosis | Latent Tuberculosis Infection

Switzerland
Validus Pharmaceuticals

Completed

Safety of SPD417 Combined With Other Psychotropic Medications in the Treatment of Bipolar I Disorder

Bipolar Disorder
Validus Pharmaceuticals

Completed

Efficacy and Safety of SPD417 in Treatment of Manic Symptoms in Adults With Bipolar I Disorder

Bipolar Disorder
Abbott

Completed

A Study to Evaluate the Interaction Between Vicodin® CR and Ethanol in Healthy Male and Female Moderate Alcohol Drinkers

Drug Interactions

Canada
University of Washington
Paul G. Allen Family Foundation

Terminated

Botox as a Treatment for Chronic Male Pelvic Pain Syndrome

Chronic Male Pelvic Pain Syndrome
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Venlafaxine Extended-Release in Depressed and Anxious Patients

Depression | Anxiety Disorders
Cordis Corporation

Completed

FIM-BR - First-in-Man Study (Brazil Part) With Sirolimus-Coated BX VELOCITY Stent

Coronary Artery Disease

Brazil
Wirral University Teaching Hospital NHS Trust

Completed

Changes in Bone Mineral Density and Fracture Risk in Patients Receiving Androgen Deprivation Therapy for Prostate Cancer

Osteoporosis

United Kingdom
Vanderbilt University
Allergan; Medtronic

Completed

Vanderbilt University Spasticity Management Program Evaluation Plan

Spasticity

United States
Inje University
GlaxoSmithKline

Unknown

Costs of Lost Productive Time Among Korean Workers With Panic Disorder and Effect of Treatment With Paroxetine Controlled Release

Panic Disorder

Korea, Republic of
Depomed

Completed

Safety and Efficacy of Gabapentin in Postherpetic Neuralgia

Neuralgia, Postherpetic

United States
Rottapharm Spain

Completed

Pharmacodynamic Trial, of Slow Release ASA, in Platelet Functionalism, a Long Term Treatment Period

Cardiovascular Disease

Spain
Icahn School of Medicine at Mount Sinai
Eli Lilly and Company

Completed

Prediction of CK-MB Release During Otherwise Successful Stenting Procedure (PREDICT)

Diabetes Mellitus

United States
Medical University Innsbruck

Completed

Randomized Trial of Ultrashort Psychotherapy vs Sustained-Release Bupropion for Smoking Cessation

Substance Abuse | Nicotine Dependence | Tobacco Dependence | Substance Dependence

Austria
Kaplan Medical Center

Unknown

Controlled Release of Oxycodone 10 mg In Pre-Medication For The Post Operative Analgesia In Elective Laparoscopic Bilateral Inguinal Hernia And Elective Laparoscopic Cholecystectomy

Elective Laproscopic Bilateral Inguinal Hernia | Elective Laproscopic Cholecystectomy
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study of the Safety and Efficacy of Desvenlafaxine Succinate for Vasomotor Symptoms in Postmenopausal Women

Menopause | Vasomotor System

United States
Pfizer

Terminated

Study Of Cabaser and Sinemet CR For The Treatment Of Nighttime Symptoms Associated With Parkinson's Disease.

Parkinson Disease

Australia, Italy, Spain
Eli Lilly and Company

Completed

Duloxetine vs. Active Comparator in the Treatment of Patients With Depression

Depression

France
Eli Lilly and Company

Completed

Duloxetine vs. Active Comparator for the Treatment of Depression

Depression

Canada
University Hospital, Basel, Switzerland

Completed

Oral Ghrelin Agonist in Healthy Subjects

Healthy Subjects
Rigshospitalet, Denmark

Unknown

Botox on Vulvar Vestibulitis

Vulvar Diseases | Vulvar Vestibulitis

Denmark
Thomas Jefferson University
GlaxoSmithKline

Completed

Wellbutrin XL, Major Depressive Disorder and Breast Cancer

Breast Cancer | Major Depressive Disorder

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating DVS-233 for Treatment of Outpatients With Major Depressive Disorder

Major Depressive Disorder
AstraZeneca

Completed

Dose Ranging, Safety and Tolerability of TOPROL-XL® Extended-Release Tablets in Hypertensive Pediatric Subjects (307A)

Hypertension

United States, Dominican Republic
University Hospital, Angers
Alfediam; UNIVALOIRE

Unknown

Microvascular Response in Diabetes Mellitus

Diabetes Mellitus

France
Abbott

Completed

Evaluate the Safety of Depakote Extended Release Tablets in the Treatment of Mania Associated With Bipolar Disorder in Children and Adolescents

Bipolar I Disorder, Manic or Mixed

United States
Shahid Beheshti University of Medical Sciences

Unknown

Effect of Percutaneous Botulinum Toxin A Injection on Natural Course of Upper Lid Retraction in Thyroid Eye Disease

Eye Diseases

Iran, Islamic Republic of
University of Pisa

Unknown

Analysis of Genetic and Environmental Parameters Influencing Growth Rate of Precocious Puberty Children (CPP-EDG 01)

Central Precocious Puberty

Italy
Laserklinik Karlsruhe

Completed

Comparative Study of the Effect of Dysport and Botox

Aging

Germany
Heidelberg University
Dietmar Hopp Stiftung; Prof. Wolfgang Stremmel

Completed

Dose Finding Study for Retarded Phosphatidylcholine in Pancolitis

Ulcerative Colitis

Germany
Abbott

Completed

The Safety and Efficacy of Divalproex Sodium Extended-Release Tablets in Migraine Prophylaxis: A Study in Adolescents

Migraine

United States
Hadassah Medical Organization

Unknown

Effect of Sustained-Release Cetylpyridinium Chloride Varnish on Streptococcus Mutans and Lactobacillus in Orthodontic Patients

Healthy
Altus Pharmaceuticals

Completed

Study of an Extended-Release, Crystalline Formulation of Recombinant Human Growth Hormone (ALTU-238) in Growth Hormone Deficient Adults to Determine Pharmacokinetics, Pharmacodynamics, and Drug Safety

Adult Growth Hormone Deficiency

United States
Advancis Pharmaceutical Corporation

Completed

APC-111 Once a Day (QD) for 7 Days vs. Penicillin Taken Four Times a Day (QID) for 10 Days in Patients With Strep Throat

Tonsillitis | Pharyngitis

United States
Kos Pharmaceuticals

Completed

The Dose Response of Niacin ER/Lovastatin on Peak Walking Time (PWT) in Patients With Intermittent Claudication - TROPIC

Intermittent Claudication | Peripheral Vascular Disease

United States
Kos Pharmaceuticals

Completed

Effect of Niacin ER/Lovastatin on Peak Walking Time & Claudication Onset Time in Patients With Intermittent Claudication

Intermittent Claudication | Peripheral Vascular Disease
Kos Pharmaceuticals

Completed

Evaluation of the Safety & Efficacy of a Combination of Niacin ER & Simvastatin in Patients With Dyslipidemia (OCEANS)

Hypercholesterolemia
Kos Pharmaceuticals

Completed

Safety & Efficacy of a Combination Niacin ER/Simvastatin in Patients With Dyslipidemia: A Dose-Ranging Study - SEACOAST

Hypercholesterolemia

3

Subscribe